We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

84 hedge funds and large institutions have $316M invested in Avadel Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 18

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

6% more capital invested

Capital invested by funds: $299M → $316M (+$16.9M)

4% more funds holding

Funds holding: 81 → 84 (+3)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $981K

Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
17
Increased
30
Reduced
18
Closed
13
Calls
–
Puts
$981K
Net Calls
-$981K
Net Calls Change
-$1.45M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$20.3M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$12.2M
3
GTC
Ghost Tree Capital
New York
+$3.73M
4
AC
Armistice Capital
New York
+$3.71M
5
BCM
Brown Capital Management
Maryland
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$20.5M
2
Invesco
Invesco
Georgia
-$4.4M
3
Deutsche Bank
Deutsche Bank
Germany
-$4M
4
JP Morgan Chase
JP Morgan Chase
New York
-$3.38M
5
HA
Heartland Advisors
Wisconsin
-$1.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
26
Janney Montgomery Scott
Pennsylvania
$2.58M +$1.32M +123,900 +107%
KFA
27
Kelleher Financial Advisors
New York
$2.02M +$466K +43,750 +30%
BIM
28
Bogle Investment Management
Massachusetts
$1.97M -$913K -85,604 -32%
Ameriprise
29
Ameriprise
Minnesota
$1.77M +$198K +18,570 +13%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$1.64M +$450K +42,249 +38%
SCM
31
Stonepine Capital Management
Oregon
$1.38M +$1.36M +128,005 New
GH
32
GAM Holding
Switzerland
$1.28M +$637K +59,700 +100%
TI
33
Turner Investments
Pennsylvania
$1.26M -$307K -28,810 -20%
CS
34
Candriam SCA
Luxembourg
$1.19M – – –
Stifel Financial
35
Stifel Financial
Missouri
$1.19M +$53.3K +5,000 +11%
B
36
Bailard
California
$1.11M +$1.1M +103,000 New
DMK
37
David M. Knott
$1.07M – – –
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.06M -$602K -56,500 -36%
COPPSERS
39
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$837K +$831K +77,918 New
IHM
40
Iguana Healthcare Management
New York
$806K +$800K +75,000 New
CCI
41
Columbus Circle Investors
$675K +$346K +32,458 +107%
DC
42
Deere & Company
Illinois
$471K – – –
Ohio Public Employees Retirement System (OPERS)
43
Ohio Public Employees Retirement System (OPERS)
Ohio
$451K +$448K +42,033 New
EVM
44
Eaton Vance Management
Massachusetts
$373K – – –
State of New Jersey Common Pension Fund D
45
State of New Jersey Common Pension Fund D
New Jersey
$354K +$135K +12,695 +63%
State Street
46
State Street
Massachusetts
$330K +$8.39K +787 +3%
ProShare Advisors
47
ProShare Advisors
Maryland
$322K +$1.82K +171 +0.6%
Bank of America
48
Bank of America
North Carolina
$320K +$42.6K +3,993 +16%
SGAM
49
Smith Group Asset Management
Texas
$320K +$318K +29,780 New
CS
50
Credit Suisse
Switzerland
$303K -$258K -24,179 -46%
1
2
3 4

AVDL Hedge Fund Activity: Q2 2016 in Review

84 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2016, worth a combined $316M — up 5.7% from $299M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AVDL positions and 13 closed out — a net gain of 4 holders — while 30 added to existing stakes and 18 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $20.3M. The largest seller was Bank of New York Mellon, cutting an estimated $20.5M.

  • 84 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2016, up from 81 in Q1 2016.
  • Funds reported $316M of Avadel Pharmaceuticals stock for Q2 2016, up 5.7% quarter-over-quarter.
  • 17 funds opened new Avadel Pharmaceuticals positions in Q2 2016 and 13 closed out, a net change of +4 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2016 was Janus Henderson Investors US, an estimated $20.3M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2016 was Bank of New York Mellon, an estimated $20.5M sold.

Based on aggregated 13F filings for Q2 2016.